The Foundation funds projects that break from traditional research paradigms and have the potential to fuel much-needed breakthroughs - and ultimately, improve brain cancer survival.
Professor Andrew Scott, who holds positions at Austin Health and the Olivia Newton-John Cancer Research Institute (La Trobe University School of Cancer Medicine) will lead a research team that will work on improving prognosis for the brain cancer glioblastoma. It is hoped that the trial will lead to the better prediction of a patient's likely response to therapy, along with their likelihood of resistance to treatment.
The team aims to achieve this by utilising an imaging technique for detecting amino acid metabolism in brain tumours using Positron Emission Tomography, in a clinical trial of over 200 patients.
Brain cancer is a devastating illness with few effective treatment options. The Cure Brain Cancer Foundation provides funding to rapidly increase Australian brain cancer research capacity, and has provided grants of more than $1 million to brain cancer researchers in the past year alone.
These week's two $200,000 Innovation Grants were given to Professor Andrew Scott of Austin Health and the Olivia Newton-John Cancer Research Institute (La Trobe University School of Cancer) and Associate Professor Lee Wong of Monash University, following a high quality and competitive application process.
Michelle Stewart, CEO of Cure Brain Cancer Foundation said, "These projects are at the cutting-edge of brain cancer research, doing things differently to improve outcomes for brain cancer patients. We must support these innovative projects if we're going to rapidly improve brain cancer survival."
Since 2013, Cure Brain Cancer Foundation has committed more than $18 million to brain cancer research, backing 41 research projects and enabled the investigation of almost 120,000 drugs.